A Multidisciplinary Approach to CLI is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy James P. Zidar, M.D., F.A.C.C., F.S.C.A.I.

Slides:



Advertisements
Similar presentations
AAWC Venous Ulcer Guideline
Advertisements

Upper vs. Lower Body Aerobic Training in Patients with Claudication Diane Treat-Jacobson, PhD, RN Assistant Professor of Nursing Center for Gerontological.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
The Vascular Lab and the Angiographic Assessment of PAD The Vascular Lab and the Angiographic Assessment of PAD John C. Lantis II, MD John C. Lantis II,
THE DIABETIC FOOT DR.SEIF I M ELMAHI MD, FRCSI University of Khartoum, Sudan.
Ulcerations Due to Peripheral Vascular Disease
Diabetic Foot: A Surgical Look Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
Slides current until 2008 Diabetic neuropathy. Curriculum Module III-7C Slide 2 of 37 Slides current until 2008 Diabetic foot disease – the high-risk.
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.) A National Public Awareness Campaign from the P.A.D. Coalition and the National Heart,
Francis Dix Consultant vascular and endovascular surgeon
PERIPHERAL VASCULAR DISEASE Valerie Robinson D.O..
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
Diabetic Foot: A Surgical Look
Identifying the Presence of Peripheral Artery Disease in Patients With and Without Diabetes Lori Brown, PharmD and Charles Herring, PharmD, BCPS, CPP University.
PERIPHERAL ARTERIAL DISEASE (PAD)
Esiti del trattamento con angioplastica transluminale percutanea (PTA) agli arti inferiori nei pazienti diabetici in trattamento dialitico con ischemia.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
MidAtlantic Vascular, LLC
MidAtlantic Vascular, LLC
Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.
Lower Extremity Vascular Disease
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
ACC/AHA 2006 guidelines on the management of PAD.
Peripheral Arterial Disease Doctor’s Name Contact Information.
Medical Management of Claudication: Just Walk it Off!!
MidAtlantic Vascular, LLC
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
(Relates to Chapter 38, “Nursing Management: Vascular Disorders,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Peripheral Artery Disease Mays, Casserly, and Regensteiner
By:Ariel Fisher RNS & Janel Canty RNS (Osborn, 2010)
Peripheral Vascular Disease
Peripheral Artery Disease (PAD)
Medical Director – Skin Oxygen Measurement Medical Director - Medical Oxygen Research Medical Director - Assistant Professor -
Lower Limb Amputations –
The angiosome theory to guide revascularization for CLI
Approach to CLI – Consider Arterial & Venous Insufficiency
The angiosome concept; open and endovascular treatment of CLI
Norway Grants Erik Staffa, Vladan Bernard, Aleš Bourek
CRT 2012 Venous Disease.
Anticoagulation after peripheral Vascular Intervention
Arteriosclerosis obliterans
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Michael Siah, M.D. Medstar Georgetown University Hospital
Antithrombotic Therapy in Peripheral Artery Disease
Crossing SFA-Popliteal Artery CTO’s
Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,
Multidisciplinary Approach for a Successful CLI Management Program
The Role of Interventional Treatment for The Failing Grafts
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Peripheral Arterial Disease
Post-Surgical Care for the Individual With PAD
Public Health Burden of CAD/PAD
L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, F
Lucy Stopher A/CNS Vascular Surgery
Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative  Peter A. Soden, MD, Sara.
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.)
PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington.
ASS.Lec. Suad Turky Ali Lec -10-
Division of Endovascular Interventions
ASS.Lec. Suad Turky Ali Lec -10-
Vascular Surgery Michael Ricci, MD.
Limb Preservation Center:The New Frontier
From Theory to Practice: Creating a limb Preservation Center
Konstantinos Katsanos Joseph Mills Sigrid Nikol Jim Reekers
Presentation transcript:

A Multidisciplinary Approach to CLI is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy James P. Zidar, M.D., F.A.C.C., F.S.C.A.I Clinical Professor of Medicine UNC Health Systems Corporate Chief of Cardiology, Rex Healthcare President, Rex Heart and Vascular Specialists Raleigh, North Carolina

James P. Zidar, MD Grant Support: Cordis Corporation Honoraria: Medtronic CoreValve Abbott Vascular

PAD ….What are the goals? Asymptomatic – treat risk factors Claudication – medical therapy or revascularization to improve symptoms Critical Limb Ischemia – prevent amputation and limb loss

Risk Factors for PAD Diabetes Hypertension Smoking Dyslipidemia Disproportionate prevalence in African Americans Slightly higher prevalence in males Increasing age Hypertension Dyslipidemia Inflammatory markers Hyperviscosity and hypercoagulable states Hyperhomocysteinemia Chronic renal insufficiency TASC II. Journal of Vascular Surgery, January 2007 REFERENCE Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) The risk factors for PAD are similar to those for coronary heart disease, although DM and cigarette smoking are particularly strong risk factors for PAD. Prevalence is diproportionate for blacks and with age Prevelance remarkably high among patients with renal insufficiency 4

Limb Loss Non-diabetics have a “relatively low” risk of either abrupt deterioration (20%) or amputation (<10%) Diabetes increases risk of amputation 6X Smoking increases risk 11X

Disease Patterns Non-Diabetics Diabetics

Diagnosis Non-invasive Invasive Bedside Ankle-Brachial Index Lower extremity Segmental Pressures and PVRs Arterial Duplex imaging MRA CTA Invasive Angiography

Assessment - baseline Non-Invasive Studies Include: Ankle Brachial Index (ABI) Toe Brachial Index (TBI) Segmental Pressures Pulse Volume Recordings (PVR) Waveforms Arterial Ultrasound TcPO2 Skin Perfusion Pressures (SPP) National guidelines-indicate necessity to rule out arterial disease with ABI/TBI for any patient with a lower extremity ulcer. American Diabetes Association suggests all diabetics >50 years of age be evaluated for PAD There are numerous non-invasive studies that can be used to further evaluate arterial disease. National guidelines-indicate a necessity to rule out arterial disease with ABI/TBI for any patient with a lower extremity ulcer. American Diabetes Association suggest all patients 50 years old or greater with DM be evaluated for PAD 8

Arterial Ultrasound Continuous-Wave Doppler Ultrasound Assess lower extremity PAD anatomy, severity, and progression Provide localizing information in patients with poorly compressible arteries Quantitative data after successful lower extremity revascularization Duplex Ultrasound Establish the diagnosis of lower extremity PAD and its anatomic location Define severity of focal extremity arterial stenoses Select candidates for endovascular or surgical revascularization Image downloaded from: http://www.pacificvascular.com/images/technicalLEAlarge.jpg December 2008 These yield valuable information regarding flow, obstructions/occlusions, and/or any other abnormalities and can demonstrates possible re-vascularization options (Donnely, R 2000) Continuous-Wave Doppler Ultrasound— This type of ultrasound is useful to assess lower extremity PAD anatomy, severity, and progression and can provide localizing information in patients with poorly compressible arteries. It also can provide quantitative data after successful lower extremity revascularization. Duplex Ultrasound—This technique can establish the diagnosis of lower extremity PAD and its anatomic location, as well as define severity of focal extremity arterial stenoses. It can be useful to select candidates for endovascular or surgical revascularization. Source: Hirsch et al; Begelman et al 9

Transcutaneous Oximetry (TcPO2) Determines the degree of microvascular/tissue perfusion of an area Predictor of Wound Healing Normal on room air - 50-90 mmHg Abnormal - 40-50 mmHg Clinically significant impaired wound healing <40 mmHg TcPO2s are useful in determining healing potential, amputation level mapping, evaluating the effectiveness of a re-vascularization procedure, and assessing the severity of peripheral arterial disease. This is a non-invasive study that is simple to perform. The patient lies recumbent while electrodes are placed on the limb at locations around the wound. Readings are taken at scheduled times. The study is performed on room air and while breathing oxygen to determine if increased oxygen may be of benefit. 10

Transcutaneous Oximetry (TcPO2) Values Condition Room Air (mmHg) 100% O2 at 1 ATA 100% O2 at 2 ATA Pressure (mmHg) Normal 50 - 90 > 300 > 700 Abnormal but not clinically significant 40 - 50 Clinically significant Impaired healing < 40 < 100 * < 200** These are the values often used to evaluate the quality of response directing further evaluation. NHC Clinical Policy and Procedure 11

Basic Treatment of CLI Medical Rx- ASA, Ace inhibitor, statin, ?clopidogrel, ?Pletal, Pin control Management of ulcer and gangrene Infection control Local Rx & pressure relief Revascularization Amputation

Revascularization of Critical Limb Ischemia - Intervention Endovascular Procedures: Percutaneous Transluminal Angioplasty (PTA) Stents Atherectomy Excisional Laser “Specialized” Angioplasty Devices Cutting and Scoring Balloons Cryoplasty Possibly Drug eluting balloon

Lifestyle changes Avoid: leg crossing, trauma, cold, friction, constrictive clothing, moisture between toes, bare feet Routine professional foot care Foot wear to off-load high risk pressure areas Supervised walking program Avoid sedentary lifestyle Nutritious diet regimen Simple lifestyle changes can reduce pain and may slow progression of the disease process until an intervention can be performed or other options are deemed appropriate (Patterson, G, 2001) 14

Reinstate arterial flow - key to wound healing Arterial Ulcer Care Reinstate arterial flow - key to wound healing Then… - Adequate debridement - Dressing choice based on wound needs Treatments that stimulate angiogenesis Negative Pressure Wound Therapy Biologic products Bioengineered tissues Growth factors Hyperbaric Oxygen Therapy Reinstating or optimizing the arterial flow is imperative for ulcer healing to occur. Once that is achieved, traditional ulcer management can begin to include debridement and appropriate topical treatments based on the ulcers needs. Treatments that stimulate angiogenesis are often used to enhance the wound healing process, decreasing the overall time to heal. NHC Marketing Library 15

Who Staffs Our 3 Wound Healing Centers 10 physicians-each staff ½ day per week 5 general surgeons 1 plastic surgeon 1 orthopedic surgeon 2 vascular surgeons 1 podiatrist Eliminate financial silos- incent group behavior

Hyperbaric Oxygen Therapy Benefits Decreases edema through vasoconstriction Improves collagen production Increases tissue oxygenation Increased oxygen tension facilitates phagocytosis Promotes neo-angiogenesis Enhances granulation tissue formation Hyperbaric oxygen therapy is one effective adjunctive modality used to stimulate angiogenesis and wound healing through various mechanisms. 17

Requirements of a Successful CLI Program Excellent primary care screening with widespread baseline non-invasive testing Wound clinic that can see patient weekly for aggressive debridement Weekly photos of the wound Hyperbaric chamber Aggressive endovascular group with an angiosome approach to revascularization. Vascular surgery support for the pt who requires open fem-tibial bypass or needs toe or forefoot amp. Eliminate financial silos- incent group behavior

Possibilities….